RIA · CRD 169355SEC-RegisteredPrivate Fund Adviser

Updated:

Q Healthcare Holdings

Q Healthcare Holdings is an SEC-registered investment adviser in Stamford, CT, registered since 2014. The firm manages $3.8 billion in assets, including $3.3...

Q Healthcare Holdings

Q Healthcare Holdings is an SEC-registered investment adviser in Stamford, CT, registered since 2014. The firm manages $3.8 billion in assets, including $3.3 billion on a discretionary basis. It has 23 employees and 19 investment advisers.

General information

Firm type

RIA

Year founded

2016

Location

Region

North America

Country

United States

City

Stamford

Corporate office

New York, NY, United States

Additional offices

San Francisco, CA · Cambridge, MA · Baltimore, MD · Boston, MA · Bethesda, MD · Doha, Qatar

Principals

Dr. Hamad Al Thani

Principal

Sector focus

Healthcare ServicesDigital HealthBiotechnologyMedical Devices

Frequently asked questions

Who controls investment decisions at Q Healthcare Holdings?

Dr. Hamad Al Thani, a member of Qatar's ruling family, serves as the principal and ultimate decision-maker. The firm does not operate with an external investment committee or third-party limited partners, giving Dr. Al Thani sole discretion over capital allocation and portfolio construction.

What investment stages does Q Healthcare Holdings typically target?

The firm targets mature, revenue-generating healthcare businesses with established reimbursement models, regulatory clearances and operational infrastructure. It generally avoids pre-revenue biotech or seed-stage digital health startups, concentrating instead on clinical services platforms, medical-device manufacturers and specialty pharmaceutical distribution with existing cash flows.

Which sectors does the firm explicitly avoid?

Q Healthcare Holdings does not invest in pure-play insurance underwriting, acute-care hospital systems with heavy government-payer exposure or consumer-wellness apps lacking FDA-regulated claims. The firm also avoids healthcare sectors where pricing power is entirely dependent on Medicare fee-schedule rates without a commercial-payer diversification pathway.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on registered investment advisers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Stamford RIA profiles